The global anesthesia and respiratory devices market size was estimated at USD 44.6 billion in 2023 and is predicted to reach around USD 84.97 billion by 2033, registering a CAGR of 6.7% during the forecast period from 2024 to 2033.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. anesthesia and respiratory devices market size was valued at USD 8.04 billion in 2024 and is estimated to reach around USD 16.28 billion by 2033, growing at a CAGR of 7.35% from 2024 to 2033.
In 2022, North America dominated the global anesthesia & respiratory devices market and is expected to reflect this trend throughout forecast period. The anesthesia and respiratory devices market in the U.S.is predicted to grow, as the number of patients undergoing from COPD is mounting quickly. It is expected that nearby 12 million people are suffering from COPD in the U.S. Growing senior population, more number of casualty surgeries accomplished and accessibility of reimbursement for respiratory and anesthesia devices are the reasons that are positively impacting market growth in the U.S.
In Asia Pacific, Japan accounted for the major share of the market on account of substantial rise in the elderly population. Emerging nations such as China and India are also projected to observe a noteworthy population suffering from pulmonary diseases. As per the data released by World Health Organization (WHO), nearby 90% of the deaths credited to COPD occur in middle-income and low nations. Likewise, as per the study circulated in the International Journal of Pulmonary and Respiratory Sciences, in India, COPD was the second biggest reason of death in 2016. Thus, rising cases of respiratory diseases across emerging countries is anticipated to further propel the growth of anesthesia & respiratory devices market in the Asia Pacific.
Growing frequency of respiratory illnesses, prompt growth in the elderly population, and pervasiveness of tobacco smoking, are some of the major factors driving the growth of global anesthesia & respiratory devices market. Further, inclination towards home-based oxygen therapy and technological innovations to develop innovative products delivering oxygen therapy further fuelling the market growth. For example, anesthesia information-management systems (AIMS) with intraoperative monitoring-device connectivity deliver influential decision-support tools with real-time clinical guidance, using machine learning algorithms to forecast stuffs such as hypotension long beforehand they befall clinically.
Requirement for anesthesia and respiratory devices are snowballing on account of stimulating occurrence of respiratory diseases, including Obstructive Sleep Apnea (OSA) and Chronic Obstructive Pulmonary Disease (COPD). Growing occurrence of the respiratory infection is anticipated to be a high-impact influencer of the market. As per Australian Institute of Health and Welfare, 1 in 20 Australians aged 45 or beyond was undergoing from COPDin 2014-15. Further, as per, World Health Organization (WHO), about 251 million cases of COPD were detected in 2016, worldwide. Additionally, as per the National Health Service (NHS), in U.K about 1.2 million people are presently suffering from COPD.
| Report Highlights | Details |
| Growth Rate from 2024 to 2033 | CAGR of 6.7% |
| Market Size in 2023 | USD 44.6 Billion |
| Market Size by 2033 | USD 84.97 Billion |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | Product Type, Region Type |
| Companies Mentioned | Philips Healthcare, Medtronic Plc., Getinge Group, Masimo, Draegerwerk AG, Smith's Medical, ResMed and Teleflex Inc., OSI Systems |
Over the past few years, foremost improvements in anesthesia equipment have been ventilation modes that were earlier only employed in ICUs. These comprise synchronized intermittent mandatory ventilation (SMMV), pressure support ventilation (PSV), and synchronized mandatory minute ventilation (SMMV) and numerous derivatives of every mode. The ventilator has ICU quality ventilation throughout all patient classes and has less flow and nominal flow anesthesia modes to recover anesthetic conveyance and decrease financial influence. Current models have incorporated novel ventilation modes and most producers are striving to upsurge the resemblances among their anesthesia and ventilator monitor interfaces.
Anesthesia devices are generally classified into disposables and machines. Anesthesia disposables comprise accessories and masks. The machine segment comprises delivery machines, workstations, ventilators and monitors. The increasing number of surgical procedures is anticipated to upsurge the practice of anesthesia, thus pushing the demand for anesthesia devices.
Respiratory equipment is categorized into oxygen concentrators, nebulizers, humidifiers, ventilators, and positive airway pressure devices, respiratory inhalers. In 2023, positive airway pressure devices conquered the whole anesthesia and respiratory devices market and are also predicted to observe noteworthy growth during years to come due to escalating occurrence of respiratory disorders including asthma, cystic fibrosis, and tuberculosis.
Segments Covered in the Report
This research report includes complete assessment of the market with the help of extensive qualitative and quantitative insights, and projections regarding the market. This report offers breakdown of market into prospective and niche sectors. Further, this research study calculates market revenue and its growth trend at global, regional, and country from 2016 to 2027. This report includes market segmentation and its revenue estimation by classifying it on the basis of product and region as follows:
By Product
By Regional Outlook
PROCEED TO BUY :
ASK FOR SAMPLE
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
